Preferred Label : Somapacitan;

UNII : 8FOJ430U94;

CAS number : 1338578-34-9;

NCI Metathesaurus CUI : CL553726;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/sogroya
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Somapacitan
Somapacitan
human growth hormone
human growth hormone
orphan drug production
hormone replacement therapy
adult
Growth Hormone Deficiency
injections, subcutaneous
product surveillance, postmarketing
Adult growth hormone deficiency (disorder)
aged
drug interactions
pregnancy
breast feeding
somapacitan
human growth hormone
Prolonged-Action preparations
drug evaluation, preclinical
Product containing only somapacitan in parenteral dose form (medicinal product form)
Delayed-Action preparations

---
Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.